LINDSAY JACKSON: Open Payments
NPI 1578252516 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $44 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $105 |
| ABBVIE INC. | 2 | $39 |
| GENZYME CORPORATION | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: REZDIFFRA, XIFAXAN, DUPIXENT, SKYRIZI, OMVOH, SUFLAVE, RINVOQ, ENTYVIO.
Industry payments across FL — which companies pay providers there.
